Status:
COMPLETED
Reduction of Mortality Prior to and During the First 90 Days of Dialysis Through a Renal Rehabilitation Program
Lead Sponsor:
MaineHealth
Conditions:
Chronic Kidney Disease
End Stage Kidney Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The mortality rate of treated patients with end stage renal disease(ESRD)is 22 deaths patient-years at risk in 2006. Incident patients with ESRD are most vulnerable within the first 90 days of dialysi...
Eligibility Criteria
Inclusion
- greater than 18 yo
- stage III CKD (GFR\<60ml/min)
- stage IV CKD (GFR\<30ml/min)
Exclusion
- active angina pectoris
- lower extremity amputation with no prosthesis
- orthopedic disorder severly exacerbated by activity
- chronic lung disease resulting in significant shortness of breath or oxygen de-saturation at rest
- cerebro cascular disease manifested by ongoing TIAs
- malignant carcinoma
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT00792454
Start Date
October 1 2008
End Date
November 1 2015
Last Update
May 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maine Nephrology Associates
Portland, Maine, United States, 04102